Access the latest insights, innovative solutions and expert content for your cardiovascular service line from Boston Scientific.
FARAPULSE™ transforms AFib treatment by delivering favorable outcomes, procedure efficiencies, and economic benefits Read how FARAPULSE can improve the clinical outcomes and reduce the costs of treating your patients with cardiac arrhythmias. |
The Power of FARAPULSE PFA for AF Management Discover how FARAPULSE helped a health system increase AFib ablation volume by 24% without additional staff or facilities. This CV business white paper by MedAxiom shows how this innovative technology is safely and efficiently maximizing existing resources. |
Best Practices for Integrating Concomitant LAAC and AF Ablation Procedures in Clinical Care Gain insights from seven experienced centers on best practices for patient selection, procedural planning, and post-procedural care. Discover how integrating LAAC and AF ablation procedures can transform clinical care in this CV business white paper by MedAxiom. |
AGENT™ Drug-Coated Balloon expands treatment options for physicians and patients Discover AGENT DCB: The only U.S. approved coronary drug-coated balloon that reduces repeat procedures and lowers long-term care costs for ISR patients. |